http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2597962-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dd865f7fe9cb958462be0478f5363ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
filingDate 2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f20adf31e5ac74d892866fdb990bafe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9f7b996dd99254e1f5734b6ad24b93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d307bed31823014f896f9e361f8a80f1
publicationDate 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2597962-T3
titleOfInvention Exendin-4 fusion protein and its analogue, method of preparation and use thereof
abstract A fusion protein, which is obtained by fusion of a peptide hormone with a transport protein through a linker, where the peptide hormone is exendin-4 or the analog of exendin-4, and the peptide hormone is capable of lowering blood glucose; the transport protein is the Fc fragment of the IgG2 immunoglobulin; the fusion protein is capable of lowering blood glucose; the exendin-4 analog is a peptide that has 6 or less differences of amino acid sites with SEQ ID No. 1; The linker is a peptide having the sequence shown by (Gly) mXaa- (Gly) n, in which, m is an integer between 3 and 8, n is an integer between 3 and 8, Xaa is one anyone selected in the group consisting of Gly, Ser, Ala and Thr.
priorityDate 2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16157882
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID517420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2740
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14652
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054

Total number of triples: 41.